The aim of this study is to describe the anatomical and functional changes observed in multiparametric magnetic resonance imaging (mpMRI) during follow-up after focal therapy (FT) for localized prostate cancer (PCa). In this prospective study, we analyzed pre- and postoperatively acquired mpMRI of 10 patients after FT (7days; 3, 6, 9, 12months). 7/10 (70%) patients underwent vascular-targeted photodynamic therapy (VTP). 3/10 (30%) patients underwent high-intensity focused ultrasound (HIFU). MpMR image analysis was performed using a semi-automatic software for segmentation of the prostate gland (PG) and tumor zones. Signal intensities (SI) of T2-weighted (T2w), T1-weighted (T1w),diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) images as well as volumes of the prostate gland (PGV) and tumor volumes (TV) were evaluated at each time point. The results showed a significant increase of PGV 7days after FT (p = 0.042) and a significant reduction of PGV between 7days and 6, 9 and 12months after FT (p < 0.001). The TV increased significantly 7days after FT (p < 0.001) and decreased significantly between 7days and 12months after FT (p < 0.001). There was a significant increase in SI of the ADC in the ablation zone after 6, 9 and 12months after FT (p < 0.001). 1/9 patients (11%) had recurrent tumor on rebiopsy characterized as a a small focal lesion on mpMRI with strong diffusion restriction (low SI on ADC map and high SI on b-value DWI). MpMRI is able to represent morphologic changes of the ablated zone after FT and might be helpful to detect recurrent tumor.